PharmaSGP Holding SE provided revenues guidance for the financial year 2022. After another record year, the company is targeting revenues of between EUR 78 million and EUR 82 million for the financial year 2022, up from EUR 65.3 million in the year before, equating to planned growth of at least 19.5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 EUR | -0.87% | -0.87% | +1.33% |
04-29 | PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.33% | 294M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PSG Stock
- News PharmaSGP Holding SE
- PharmaSGP Holding SE Provides Revenues Guidance for the Financial Year 2022